Selected research
Market Analysis & Forecast
Global Clinical Laboratory Testing Service Market Analysis and Forecast 2026-2032
Market perspective
The global Clinical Laboratory Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Clinical Laboratory Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Clinical Laboratory Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Clinical Laboratory Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Clinical Laboratory Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Clinical Laboratory Testing Service include SGS, LabCorp, Cerba Research, IQVIA Q² Solutions, Eurofins, Charles River, ACM Global Laboratories, Australian Clinical Labs and PPD, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Clinical Laboratory Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Clinical Laboratory Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Clinical Laboratory Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Laboratory Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Clinical Laboratory Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Clinical Laboratory Testing Service revenue, projected growth trends, production technology, application and end-user industry.
Clinical Laboratory Testing Service Segment by Company
SGS
LabCorp
Cerba Research
IQVIA Q² Solutions
Eurofins
Charles River
ACM Global Laboratories
Australian Clinical Labs
PPD
Almac Group
Mayo Clinic
LabConnect
Pharmaron
Frontage
WuXi AppTec
CTI
KingMed
CIRS
Clinical Laboratory Testing Service Segment by Type
Central Laboratory Services
Clinical Bioanalysis Services
Genomics and Biomarkers
Other Services
Clinical Laboratory Testing Service Segment by Application
Pharmaceuticals
Biotechnology
Medical Devices
Other
Clinical Laboratory Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Laboratory Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Laboratory Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Laboratory Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Clinical Laboratory Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Clinical Laboratory Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Laboratory Testing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Central Laboratory Services
- Clinical Bioanalysis Services
- Genomics and Biomarkers
- Other Services
Applications
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Other
Companies covered
- SGS
- LabCorp
- Cerba Research
- IQVIA Q² Solutions
- Eurofins
- Charles River
- ACM Global Laboratories
- Australian Clinical Labs
- PPD
- Almac Group
- Mayo Clinic
- LabConnect
- Pharmaron
- Frontage
- WuXi AppTec
- CTI
- KingMed
- CIRS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Clinical Laboratory Testing Service Market by Type
- 1.2.1 Global Clinical Laboratory Testing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Central Laboratory Services
- 1.2.3 Clinical Bioanalysis Services
- 1.2.4 Genomics and Biomarkers
- 1.2.5 Other Services
- 1.3 Clinical Laboratory Testing Service Market by Application
- 1.3.1 Global Clinical Laboratory Testing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Biotechnology
- 1.3.4 Medical Devices
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Clinical Laboratory Testing Service Market Dynamics
- 2.1 Clinical Laboratory Testing Service Industry Trends
- 2.2 Clinical Laboratory Testing Service Industry Drivers
- 2.3 Clinical Laboratory Testing Service Industry Opportunities and Challenges
- 2.4 Clinical Laboratory Testing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Clinical Laboratory Testing Service Market Perspective (2021-2032)
- 3.2 Global Clinical Laboratory Testing Service Growth Trends by Region
- 3.2.1 Global Clinical Laboratory Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Clinical Laboratory Testing Service Market Size by Region (2021-2026)
- 3.2.3 Global Clinical Laboratory Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Clinical Laboratory Testing Service Revenue by Players
- 4.1.1 Global Clinical Laboratory Testing Service Revenue by Players (2021-2026)
- 4.1.2 Global Clinical Laboratory Testing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Clinical Laboratory Testing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Clinical Laboratory Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Clinical Laboratory Testing Service Key Players Headquarters & Area Served
- 4.4 Global Clinical Laboratory Testing Service Players, Product Type & Application
- 4.5 Global Clinical Laboratory Testing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Clinical Laboratory Testing Service Market CR5 and HHI
- 4.6.3 2025 Clinical Laboratory Testing Service Tier 1, Tier 2, and Tier 3
5 Clinical Laboratory Testing Service Market Size by Type
- 5.1 Global Clinical Laboratory Testing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 5.3 Global Clinical Laboratory Testing Service Revenue Market Share by Type (2021-2032)
6 Clinical Laboratory Testing Service Market Size by Application
- 6.1 Global Clinical Laboratory Testing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 6.3 Global Clinical Laboratory Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Clinical Laboratory Testing Service Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 LabCorp
- 7.2.1 LabCorp Company Information
- 7.2.2 LabCorp Business Overview
- 7.2.3 LabCorp Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 LabCorp Clinical Laboratory Testing Service Product Portfolio
- 7.2.5 LabCorp Recent Developments
- 7.3 Cerba Research
- 7.3.1 Cerba Research Company Information
- 7.3.2 Cerba Research Business Overview
- 7.3.3 Cerba Research Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Cerba Research Clinical Laboratory Testing Service Product Portfolio
- 7.3.5 Cerba Research Recent Developments
- 7.4 IQVIA Q² Solutions
- 7.4.1 IQVIA Q² Solutions Company Information
- 7.4.2 IQVIA Q² Solutions Business Overview
- 7.4.3 IQVIA Q² Solutions Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 IQVIA Q² Solutions Clinical Laboratory Testing Service Product Portfolio
- 7.4.5 IQVIA Q² Solutions Recent Developments
- 7.5 Eurofins
- 7.5.1 Eurofins Company Information
- 7.5.2 Eurofins Business Overview
- 7.5.3 Eurofins Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Eurofins Clinical Laboratory Testing Service Product Portfolio
- 7.5.5 Eurofins Recent Developments
- 7.6 Charles River
- 7.6.1 Charles River Company Information
- 7.6.2 Charles River Business Overview
- 7.6.3 Charles River Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Charles River Clinical Laboratory Testing Service Product Portfolio
- 7.6.5 Charles River Recent Developments
- 7.7 ACM Global Laboratories
- 7.7.1 ACM Global Laboratories Company Information
- 7.7.2 ACM Global Laboratories Business Overview
- 7.7.3 ACM Global Laboratories Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 ACM Global Laboratories Clinical Laboratory Testing Service Product Portfolio
- 7.7.5 ACM Global Laboratories Recent Developments
- 7.8 Australian Clinical Labs
- 7.8.1 Australian Clinical Labs Company Information
- 7.8.2 Australian Clinical Labs Business Overview
- 7.8.3 Australian Clinical Labs Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Australian Clinical Labs Clinical Laboratory Testing Service Product Portfolio
- 7.8.5 Australian Clinical Labs Recent Developments
- 7.9 PPD
- 7.9.1 PPD Company Information
- 7.9.2 PPD Business Overview
- 7.9.3 PPD Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 PPD Clinical Laboratory Testing Service Product Portfolio
- 7.9.5 PPD Recent Developments
- 7.10 Almac Group
- 7.10.1 Almac Group Company Information
- 7.10.2 Almac Group Business Overview
- 7.10.3 Almac Group Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Almac Group Clinical Laboratory Testing Service Product Portfolio
- 7.10.5 Almac Group Recent Developments
- 7.11 Mayo Clinic
- 7.11.1 Mayo Clinic Company Information
- 7.11.2 Mayo Clinic Business Overview
- 7.11.3 Mayo Clinic Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Mayo Clinic Clinical Laboratory Testing Service Product Portfolio
- 7.11.5 Mayo Clinic Recent Developments
- 7.12 LabConnect
- 7.12.1 LabConnect Company Information
- 7.12.2 LabConnect Business Overview
- 7.12.3 LabConnect Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 LabConnect Clinical Laboratory Testing Service Product Portfolio
- 7.12.5 LabConnect Recent Developments
- 7.13 Pharmaron
- 7.13.1 Pharmaron Company Information
- 7.13.2 Pharmaron Business Overview
- 7.13.3 Pharmaron Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Pharmaron Clinical Laboratory Testing Service Product Portfolio
- 7.13.5 Pharmaron Recent Developments
- 7.14 Frontage
- 7.14.1 Frontage Company Information
- 7.14.2 Frontage Business Overview
- 7.14.3 Frontage Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Frontage Clinical Laboratory Testing Service Product Portfolio
- 7.14.5 Frontage Recent Developments
- 7.15 WuXi AppTec
- 7.15.1 WuXi AppTec Company Information
- 7.15.2 WuXi AppTec Business Overview
- 7.15.3 WuXi AppTec Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.15.4 WuXi AppTec Clinical Laboratory Testing Service Product Portfolio
- 7.15.5 WuXi AppTec Recent Developments
- 7.16 CTI
- 7.16.1 CTI Company Information
- 7.16.2 CTI Business Overview
- 7.16.3 CTI Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.16.4 CTI Clinical Laboratory Testing Service Product Portfolio
- 7.16.5 CTI Recent Developments
- 7.17 KingMed
- 7.17.1 KingMed Company Information
- 7.17.2 KingMed Business Overview
- 7.17.3 KingMed Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.17.4 KingMed Clinical Laboratory Testing Service Product Portfolio
- 7.17.5 KingMed Recent Developments
- 7.18 CIRS
- 7.18.1 CIRS Company Information
- 7.18.2 CIRS Business Overview
- 7.18.3 CIRS Clinical Laboratory Testing Service Revenue and Gross Margin (2021-2026)
- 7.18.4 CIRS Clinical Laboratory Testing Service Product Portfolio
- 7.18.5 CIRS Recent Developments
8 North America
- 8.1 North America Clinical Laboratory Testing Service Revenue (2021-2032)
- 8.2 North America Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 8.2.1 North America Clinical Laboratory Testing Service Revenue by Type (2021-2026)
- 8.2.2 North America Clinical Laboratory Testing Service Revenue by Type (2027-2032)
- 8.3 North America Clinical Laboratory Testing Service Revenue Share by Type (2021-2032)
- 8.4 North America Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 8.4.1 North America Clinical Laboratory Testing Service Revenue by Application (2021-2026)
- 8.4.2 North America Clinical Laboratory Testing Service Revenue by Application (2027-2032)
- 8.5 North America Clinical Laboratory Testing Service Revenue Share by Application (2021-2032)
- 8.6 North America Clinical Laboratory Testing Service Revenue by Country
- 8.6.1 North America Clinical Laboratory Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Clinical Laboratory Testing Service Revenue by Country (2021-2026)
- 8.6.3 North America Clinical Laboratory Testing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Clinical Laboratory Testing Service Revenue (2021-2032)
- 9.2 Europe Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 9.2.1 Europe Clinical Laboratory Testing Service Revenue by Type (2021-2026)
- 9.2.2 Europe Clinical Laboratory Testing Service Revenue by Type (2027-2032)
- 9.3 Europe Clinical Laboratory Testing Service Revenue Share by Type (2021-2032)
- 9.4 Europe Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 9.4.1 Europe Clinical Laboratory Testing Service Revenue by Application (2021-2026)
- 9.4.2 Europe Clinical Laboratory Testing Service Revenue by Application (2027-2032)
- 9.5 Europe Clinical Laboratory Testing Service Revenue Share by Application (2021-2032)
- 9.6 Europe Clinical Laboratory Testing Service Revenue by Country
- 9.6.1 Europe Clinical Laboratory Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Clinical Laboratory Testing Service Revenue by Country (2021-2026)
- 9.6.3 Europe Clinical Laboratory Testing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Clinical Laboratory Testing Service Revenue (2021-2032)
- 10.2 China Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 10.2.1 China Clinical Laboratory Testing Service Revenue by Type (2021-2026)
- 10.2.2 China Clinical Laboratory Testing Service Revenue by Type (2027-2032)
- 10.3 China Clinical Laboratory Testing Service Revenue Share by Type (2021-2032)
- 10.4 China Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 10.4.1 China Clinical Laboratory Testing Service Revenue by Application (2021-2026)
- 10.4.2 China Clinical Laboratory Testing Service Revenue by Application (2027-2032)
- 10.5 China Clinical Laboratory Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Clinical Laboratory Testing Service Revenue (2021-2032)
- 11.2 Asia Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 11.2.1 Asia Clinical Laboratory Testing Service Revenue by Type (2021-2026)
- 11.2.2 Asia Clinical Laboratory Testing Service Revenue by Type (2027-2032)
- 11.3 Asia Clinical Laboratory Testing Service Revenue Share by Type (2021-2032)
- 11.4 Asia Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 11.4.1 Asia Clinical Laboratory Testing Service Revenue by Application (2021-2026)
- 11.4.2 Asia Clinical Laboratory Testing Service Revenue by Application (2027-2032)
- 11.5 Asia Clinical Laboratory Testing Service Revenue Share by Application (2021-2032)
- 11.6 Asia Clinical Laboratory Testing Service Revenue by Country
- 11.6.1 Asia Clinical Laboratory Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Clinical Laboratory Testing Service Revenue by Country (2021-2026)
- 11.6.3 Asia Clinical Laboratory Testing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Clinical Laboratory Testing Service Revenue (2021-2032)
- 12.2 SAMEA Clinical Laboratory Testing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Clinical Laboratory Testing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Clinical Laboratory Testing Service Revenue by Type (2027-2032)
- 12.3 SAMEA Clinical Laboratory Testing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Clinical Laboratory Testing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Clinical Laboratory Testing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Clinical Laboratory Testing Service Revenue by Application (2027-2032)
- 12.5 SAMEA Clinical Laboratory Testing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Clinical Laboratory Testing Service Revenue by Country
- 12.6.1 SAMEA Clinical Laboratory Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Clinical Laboratory Testing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Clinical Laboratory Testing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst